DARPA starts blood manufacturing project

06/12/2007 | United Press International

The Defense Advanced Research Projects Agency hopes to grow Type O negative blood outside of the body to help limit combat deaths, many of which occur due to blood loss. The program seeks to develop an automated progenitor cell-based culture system to create normal red blood cells. The group also will look for ways to extend the shelf life of blood donations.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL